Stock Scorecard
Stock Summary for Cigna Group (The) (CI) - $271.71 as of 2/5/2026 7:15:54 AM EST
Total Score
13 out of 30
Safety Score
65 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for CI
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for CI
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for CI
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for CI
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for CI (65 out of 100)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 2 |
| Book Value (Max of 10) | 10 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 5 |
| Dividend Yield Percentage (Max of 10) | 4 |
| Operating Margin (Max of 10) | 1 |
| Trading Volume (Max of 10) | 9 |
| Price to Earnings (Max of 10) | 9 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for CI
Financial Details for CI
Company Overview |
|
|---|---|
| Ticker | CI |
| Company Name | Cigna Group (The) |
| Country | USA |
| Description | Cigna Corporation (CI), headquartered in Bloomfield, Connecticut, is a leading American multinational health services organization that specializes in a wide range of insurance products, including medical, dental, disability, life, and accident coverage. The company serves a diverse clientele, including employers, governmental agencies, and unions, with a strong emphasis on leveraging innovative technology and personalized care solutions to enhance health outcomes. Cigna's strategic focus on integrated health services and commitment to improving customer well-being position it favorably to navigate the increasingly complex healthcare environment and capitalize on growth opportunities within the sector. |
| Sector Name | HEALTHCARE |
| Industry Name | HEALTHCARE PLANS |
| Most Recent Quarter | 9/30/2025 |
| Next Earnings Date | 2/5/2026 |
Stock Price History |
|
| Last Day Price | 271.71 |
| Price 4 Years Ago | 313.66 |
| Last Day Price Updated | 2/5/2026 7:15:54 AM EST |
| Last Day Volume | 1,366,138 |
| Average Daily Volume | 1,494,955 |
| 52-Week High | 344.64 |
| 52-Week Low | 238.17 |
| Last Price to 52 Week Low | 14.08% |
Valuation Measures |
|
| Trailing PE | 12.20 |
| Industry PE | 12.20 |
| Sector PE | 34.82 |
| 5-Year Average PE | 11.60 |
| Free Cash Flow Ratio | 12.05 |
| Industry Free Cash Flow Ratio | 12.05 |
| Sector Free Cash Flow Ratio | 33.33 |
| Current Ratio Most Recent Quarter | 0.83 |
| Total Cash Per Share | 22.55 |
| Book Value Per Share Most Recent Quarter | 156.81 |
| Price to Book Ratio | 1.76 |
| Industry Price to Book Ratio | 1.76 |
| Sector Price to Book Ratio | 53.77 |
| Price to Sales Ratio Twelve Trailing Months | 0.27 |
| Industry Price to Sales Ratio Twelve Trailing Months | 0.27 |
| Sector Price to Sales Ratio Twelve Trailing Months | 17.66 |
| Analyst Buy Ratings | 15 |
| Analyst Strong Buy Ratings | 6 |
Share Statistics |
|
| Total Shares Outstanding | 267,126,000 |
| Market Capitalization | 72,580,805,460 |
| Institutional Ownership | 91.28% |
Dividends |
|
| Ex-Dividend Date | 12/4/2025 |
| Previous Dividend Amount | 1.5100 |
| Current Dividend Amount | 1.5100 |
| Total Years Dividend Increasing | 5 |
| Trailing Annual Dividend Rate | 6.04 |
| Trailing Annual Dividend Yield | 2.20% |
| Forward Annual Dividend Rate | 6.04 |
| Forward Annual Dividend Yield | 2.20% |
| 5-Year Dividend Payments Count | 20 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 7.86% |
| 3-Year Dividend Growth Rate Percentage | 10.80% |
| 5-Year Dividend Growth Rate Percentage | 10.85% |
| All-Time Dividend Growth Rate Percentage | 12.41% |
| Dividend Payout Ratio | 26.46% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 165.40% |
| Annual Earnings Growth | -33.50% |
| Reported EPS 12 Trailing Months | 22.58 |
| Reported EPS Past Year | 21.77 |
| Reported EPS Prior Year | 27.34 |
| Net Income Twelve Trailing Months | 6,147,000,000 |
| Net Income Past Year | 3,434,000,000 |
| Net Income Prior Year | 5,164,000,000 |
| Quarterly Revenue Growth YOY | 9.50% |
| 5-Year Revenue Growth | 9.98% |
| Operating Margin Twelve Trailing Months | 4.00% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 6,025,000,000 |
| Total Cash Past Year | 7,550,000,000 |
| Total Cash Prior Year | 7,822,000,000 |
| Net Cash Position Most Recent Quarter | -24,922,000,000 |
| Net Cash Position Past Year | -21,387,000,000 |
| Long Term Debt Past Year | 28,937,000,000 |
| Long Term Debt Prior Year | 28,155,000,000 |
| Total Debt Most Recent Quarter | 30,947,000,000 |
| Equity to Debt Ratio Past Year | 0.59 |
| Equity to Debt Ratio Most Recent Quarter | 0.57 |
| Total Stockholder Equity Past Year | 41,033,000,000 |
| Total Stockholder Equity Prior Year | 46,223,000,000 |
| Total Stockholder Equity Most Recent Quarter | 41,805,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 7,437,000,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 27.84 |
| Free Cash Flow Past Year | 8,957,000,000 |
| Free Cash Flow Prior Year | 10,240,000,000 |
Options |
|
| Put/Call Ratio | 1.66 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.00 |
| MACD Signal | 0.00 |
| 20-Day Bollinger Lower Band | 0.00 |
| 20-Day Bollinger Middle Band | 0.00 |
| 20-Day Bollinger Upper Band | 0.00 |
| Beta | 0.28 |
| RSI | 0.00 |
| 50-Day SMA | 0.00 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 2/4/2026 8:01:25 PM EST |